Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia (CEBATI)

March 31, 2023 updated by: Pacific Institute of Medical Sciences

A Randomized, Open Label, Sleep Hygiene Controlled 6-Week Study to Compare the Efficacy of Four (CBT-I, FOA, Combined CBT-I and FOA and Sleep Hygiene) Different Behavioral Approaches for the Treatment of Adult Subjects With Insomnia

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I); Focus of Attention (FOA); Combined CBT-I and FOA; and Sleep Hygiene (control group) for the treatment of insomnia. This study is a randomized, open label study, and the participants are asked to assess the benefits they get from the intervention. This study involve 6 weekly in person one-to-one sessions after screening and completion of the 1-week, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administering the treatment. The Research Department will administer the outcome measures. The review of insomnia improvement will be assessed at at end of treatment, 3 months, 6 months and 12 months follow-up.

Study Overview

Detailed Description

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I), Focus of Attention (FOA), Combined CBT-I and FOA and Sleep Hygiene) of therapies approaches for the treatment of insomnia. This study is a randomized, open label study, the participants are asked to review the benefits they get from the intervention. This study involve 6 weekly sessions after screening and completion of the end of treatment, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administer study scales during therapy session. The subjective review of insomnia improvement will be assessed at end of treatment, 3 months, 6 months and 12 months follow-up assessment. Subjects are adult who meet, DSM-5 the diagnostic criteria for primary Insomnia.

Inclusion/Exclusion criteria to be assessed at Screening (Visit 1) and Visit 2. For those found eligible who complete the study, participation will include Screening (Visit 1), 6 weekly sessions after screening, and completion of the post-treatment and 6-month followup assessment.

Once subject sign the consent form, subject will be asked inclusion and exclusion criteria and will be given details about the study as per protocol.

Those eligible will be randomly assigned to one of four behavioral treatment approaches. The participant will have six weekly one hour in person sessions in which the assigned treatment will be administered. The participant will be assessed at the end of treatment and again at 6 month followup.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Max Hines, Ph.D
  • Phone Number: 425-949-5779/ 425-223-2304
  • Email: max@pspc.org

Study Contact Backup

Study Locations

    • Washington
      • Bothell, Washington, United States, 98011
        • Puget Sound Psychiatric Center
      • Bothell, Washington, United States, 98011
        • Puget Sound Psychiatry Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 72 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female outpatients who are 18 or older to 72 years. Insomnia Severity Index > or = 10
  • Meet diagnostic criteria for Insomnia Disorder per DSM-5 Willing and able to sign Informed consent form Not planning on moving away from the area for the subsequent 12 weeks.

Exclusion Criteria:

  • Participants who answer "yes" to any of the following will be excluded:
  • Females who are lactating or who are pregnant
  • Night shift workers, and individuals who nap 3 or more times per week over the preceding month
  • Consumption of caffeine beverages (i.e. tea, coffee, or cola) comprising usually more than 5 cups or glasses per day
  • Participation in another trial for insomnia
  • Persons unable to complete the study questionnaires and psychological tests
  • Persons who are unable to participate for the entire duration of the study, or in the opinion of the investigators, are likely to be non-compliant with the obligations inherent in the trial participation
  • Persons self-describing with severe anxiety or severe depression (BDI score of 29 or higher) or severe anxiety (BAI score of 36 or higher).
  • Persons with a history of epilepsy, seizures, or dementia
  • Any significant, severe or unstable, acute or chronically progressive medical or surgical condition
  • Serious head injury or stroke within the past year
  • Current alcohol or substance abuse/dependence (must have >90 days of sobriety)
  • Presence of other neurological disorders (e.g., multiple sclerosis, Parkinson's Disease)
  • Presence of an untreated or unstable medical or psychiatric comorbid condition (e.g., major depressive disorder or psychotic disorder requiring admission within the last two years). People using psychotropic medication, hypnotic or sedative medications may be included if they are on a stable dosage for the last 2 months prior to the study, if the dose remains stable throughout the study, and if the medication is judged to not interfere with the study outcomes.
  • Currently on medications known to produce insomnia (e.g., stimulants)
  • Sleep apnea (AHI >15) or previous diagnosis of sleep apnea. Study participants who use a continuous positive airway pressure (CPAP) device for sleep apnea will be eligible for participation if they are below the apnea/hypopnea cutoff while using CPAP and agree to use the device during study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Cognitive Behavior Therapy-Insomnia
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Active Comparator: Focus Of Attention
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Active Comparator: Combined-CBT-I and FOA Group
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Active Comparator: Sleep Hygiene
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self Report Sleep Measures
Time Frame: through study completion, an average of 1 year
SRSM: assess overall quantity of sleep satisfaction on the Self Report Sleep Measures.
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index
Time Frame: through study completion, an average of 1 year
ISI: assess the severity of insomnia.
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Max Hines, Ph.D, Puget Sound Psychiatry Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2018

Primary Completion (Actual)

November 1, 2021

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

December 22, 2017

First Submitted That Met QC Criteria

March 5, 2018

First Posted (Actual)

March 12, 2018

Study Record Updates

Last Update Posted (Actual)

April 5, 2023

Last Update Submitted That Met QC Criteria

March 31, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Finding to present in peer review journals

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Insomnia

Clinical Trials on Cognitive Behavior Therapy-Insomnia

3
Subscribe